(S)-(+)-Ibuprofen - CAS 51146-56-6
Catalog number: 51146-56-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C13H18O2
Molecular Weight:
206.28
COA:
Inquire
Targets:
Cox-2 | COX
Description:
Be capable of inhibiting cyclooxygenase (COX) at clinically relevant concentrations; As an enantiomer of (R)-(-)-Ibuprofen, it more potently inhibits COX activity; A non-steroidal anti-inflammatory drug
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
Be capable of inhibiting cyclooxygenase (COX) at clinically relevant concentrations; As an enantiomer of (R)-(-)-Ibuprofen, it more potently inhibits COX activity; A non-steroidal anti-inflammatory drug
Appearance:
White to Off-White Solid
Synonyms:
(S)-Ibuprofen
Solubility:
100mMin DMSO;100mM in ethanol; dichloromethane, ethyl acetate, and methanol;
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
MSDS:
Inquire
Quality Standard:
In-house
Quantity:
Grams-Kilos
Melting Point:
45-47°C
InChIKey:
HEFNNWSXXWATRW-JTQLQIEISA-N
InChI:
1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1
Canonical SMILES:
CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
1.Influence of temperature on toxicity of single pharmaceuticals and mixtures, in the crustacean A. desmarestii.
Nieto E1, Hampel M2, González-Ortegón E3, Drake P4, Blasco J4. J Hazard Mater. 2016 Mar 24;313:159-169. doi: 10.1016/j.jhazmat.2016.03.061. [Epub ahead of print]
Lethal and sublethal responses of the shrimp Atyaephyra desmarestii exposed to three pharmaceutical compounds, Diclofenac (DF), Ibuprofen (IB) and Carbamazepine (CBZ), individually and in mixtures, were evaluated under two temperature scenarios. LC50 (96h) values were obtained individually at 20° and 25°C. At 25°C, mortality in binary and ternary mixtures is higher than at 20°C. The toxicity of the mixtures was predicted on the basis of individual mortality data using two toxicity models: Concentration addition (CA) and Independent action (IA). Our results showed that neither CA nor IA unequivocally predicted the observed toxicity of binary and ternary mixtures. For sublethal toxicity, selected endpoints were: ingestion rate, osmoregulatory capacity and respiration rate. Regarding osmoregulatory capacity, no significant differences were found. The highest ingestion rates were recorded in organisms exposed at 25°C, irrespective of the compound, after 30 and 60min of exposure.
2.Active removal of ibuprofen by Money plant enhanced by ferrous ions.
Chehrenegar B1, Hu J2, Ong SL1. Chemosphere. 2016 Feb;144:91-6. doi: 10.1016/j.chemosphere.2015.08.060. Epub 2015 Sep 5.
In this study, the removal of ibuprofen (IBP), a pharmaceutical compound, from aqueous media by Money plant (Epipremnum aureum) was investigated. The effect of ferrous iron (Fe(2+)) on enhancing the IBP removal rate was also analyzed. The first-order removal rate constants showed higher values for lower IBP initial concentrations in the range of 0.20-0.28 d(-1) for an initial concentration of 125 μg L(-1) to 0.03-0.13 d(-1) for an initial concentration of 1000 μg L(-1). Introducing ferrous iron to the aqueous media enhanced the first-order removal rate constant up to 6.5 times in a 3 d time period. Along with the removal of IBP from the media, the endogenous concentration of H2O2 also decreased presumably by the production of hydroxyl radical (·OH). Reduction in the endogenous H2O2 concentration was recorded to be 38% and 98% in the absence and presence of Fe(2+) respectively in the first day and the H2O2 level remained considerably low until day 7 which then gradually increased slightly.
3.Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Pelletier JP1, Martel-Pelletier J2, Rannou F3, Cooper C4. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S22-7. doi: 10.1016/j.semarthrit.2015.11.009. Epub 2015 Dec 2.
Non-steroidal anti-inflammatory drugs (NSAIDs) are at the cornerstone of treatment for osteoarthritis (OA). In recent years, the widespread use of oral NSAIDs has been called into question due to the appearance of significant upper gastrointestinal (GI) complications and cardiovascular (CV) adverse events (AEs). However, NSAIDs are non-homogeneous, and there are noticeable differences between them in AE risk for GI and CV events. Nevertheless, if properly prescribed oral NSAIDs can provide an effective and safe treatment for OA in real-life situations. The identification of patients with significant CV and/or GI risk is critical, and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) treatment algorithm provides guidance on appropriate treatments for OA patients with elevated risk. Among non-selective NSAIDs, ibuprofen and naproxen seem preferable to diclofenac, the latter being associated with higher CV risk.
4.Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes.
Harada H, Toyoda Y, Endo T, Kobayashi M. Pharmazie. 2015 Oct;70(10):678-83.
Although chemical trapping has been widely used to evaluate cytochrome P450-mediated drug bioactivation, thus far, only a few in vitro-trapping studies have been performed on UDP-glucuronosyltransferase (UGT)-mediated drug bioactivation. In this study, we used cysteine (Cys) as trapping agent to gain new insights into the UGT-mediated bioactivation involving acyl glucuronides of carboxylic acid drugs. Diclofenac, ketoprofen and ibuprofen were incubated in human liver microsomes with UDPGA and Cys, followed by analysis using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). The N-acyl-Cys amide adduct of diclofenac was characterized by mass analysis and was detectable even in photodiode array analysis. Our data indicated that the formation of such adducts reflects the reactivity of the corresponding acyl glucuronides. In addition, it was suggested that the adduct formation requires an N-terminal Cys moiety with both a free amine and a free thiol group, from the results using various cysteine derivatives.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Cox-2 Products


CAS 181695-72-7 Valdecoxib

Valdecoxib
(CAS: 181695-72-7)

A selective COX-2 inhibitor

CAS 89796-99-6 Aceclofenac

Aceclofenac
(CAS: 89796-99-6)

Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac. It is used for the relief of pain and inflammation in rheumatoid arthritis, ...

CAS 51146-57-7 (R)-(-)-Ibuprofen

(R)-(-)-Ibuprofen
(CAS: 51146-57-7)

An inhibitor of Cox-1 and Cox-2;A nonsteroidal anti-inflammatory drug

CAS 88149-94-4 DuP-697

DuP-697
(CAS: 88149-94-4)

A selective COX-2 inhibitor

CAS 69-72-7 Salicylic acid

Salicylic acid
(CAS: 69-72-7)

Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity. It is widely used in organ...

CAS 99464-64-9 Ampiroxicam

Ampiroxicam
(CAS: 99464-64-9)

Ampiroxicam is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory drug.

N-acetyl-2-carboxy Benzenesulfonamide
(CAS: 849067-18-1)

A COX-1/COX-2 inhibitor

CAS 6385-02-0 Meclofenamate Sodium

Meclofenamate Sodium
(CAS: 6385-02-0)

A dual COX-1/COX-2 inhibitor with IC50 of 40 nM and 50 nM, respectively

O-Acetyl Salicylhydroxamic Acid
(CAS: 199854-00-7)

An irreversible, non-selective inhibitor of COX-1 and COX-2

CAS 154355-75-6 COX/5-LO-IN-1

COX/5-LO-IN-1
(CAS: 154355-75-6)

A dual inhibitor of cylooxygenase and 5-lipoxygenase

CAS 36322-90-4 Piroxicam

Piroxicam
(CAS: 36322-90-4)

Piroxicam is a non-selective COX inhibitor with an IC50 of 6 mM.

CAS 50-78-2 Aspirin

Aspirin
(CAS: 50-78-2)

A salicylate and irreversible COX1 and COX2 inhibitor

CAS 53-86-1 Indomethacin

Indomethacin
(CAS: 53-86-1)

A nonselective COX1 and COX2 inhibitor with IC50 of 0.1 μg/mL and 5 μg/mL, respectively

CAS 103-90-2 Acetaminophen

Acetaminophen
(CAS: 103-90-2)

A selective COX-2 inhibitor

CAS 156897-06-2 Licofelone

Licofelone
(CAS: 156897-06-2)

A dual inhibitor of COX-1/COX-2 and 5-LO

CAS 168433-84-9 SC58451

SC58451
(CAS: 168433-84-9)

SC58451 is a potent and selective Cox-2 (IC50= 1.1 nM) and was found to be orally active (EDs0 = 0.3 mpk) in the rat<br/>adjuvant-induced arthritis model with n...

CAS 198470-84-7 Parecoxib

Parecoxib
(CAS: 198470-84-7)

The prodrug Parecoxib as well as its active metabolite val have a specific affinity to the cannabinoid (CB) receptor measured in CB1-expressing HEK 293 cells an...

CAS 169590-42-5 Celecoxib

Celecoxib
(CAS: 169590-42-5)

A highly selective COX-2 inhibitor

COX-2 Inhibitor II
(CAS: 181696-33-3)

A selective inhibitor of Cox-2

CAS 61-68-7 Mefenamic Acid

Mefenamic Acid
(CAS: 61-68-7)

A competitive inhibitor of COX-1 and COX-2

Chemical Structure

CAS 51146-56-6 (S)-(+)-Ibuprofen

Quick Inquiry

Verification code

Featured Items